Back to results
US 2019/0316213 A1Published application
Validation of continuous viral clearance
AssigneeBayer Aktiengesellschaft
InventorsBenjamin MAISER, Peter SCHWAN, Laura DAVID, Martin LOBEDANN
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method for validation of continuous viral clearance comprising the steps of providing a probe to be validated, spiking the probe in a valid manner, performing viral clearance, sampling the spiked probe and analyzing the sample of the spiked probe of step d).
Claims11
A method for validation of continuous viral clearance comprising
- a) providing a probe to be validated,
- b) spiking the probe in a valid manner
- c) performing viral clearance,
- d) sampling the spiked probe and
- e) analyzing the sample of the spiked probe of d).
2 more elements
Dependencies are inferred from the claim text.